x
Filter:
Filters applied
- Pathway of the Month
- Bebb, GwynRemove Bebb, Gwyn filter
- ChemokinesRemove Chemokines filter
- CXCR4Remove CXCR4 filter
Pathway of the Month
1 Results
- Pathway of the MonthOpen Archive
The CXCR4/SDF-1 Chemokine Receptor Axis: A New Target Therapeutic for Non-small Cell Lung Cancer
Journal of Thoracic OncologyVol. 3Issue 12p1379–1383Published in issue: December, 2008- Shannon Otsuka
- Gwyn Bebb
Cited in Scopus: 55Chemokines are proinflammatory chemoattractant cytokines that regulate cell trafficking and adhesion. The CXCR4 chemokine receptor and its ligand, stromal cell derived factor (SDF-1), constitute a chemokine/receptor axis that has attracted great interest because of an increasing understanding of its role in cancer, including lung cancer. The CXCR4/SDF-1 complex activates several pathways that mediate chemotaxis, migration and secretion of angiopoietic factors. Neutralization of SDF-1 by anti-SDF-1 or anti-CXCR4 monoclonal antibody in preclinical in vivo studies results in a significant decrease of non-small cell lung cancer metastases.